Valuation: Bayer AG

Market Cap 54.6B 60.88B 49.9B 45.55B 85.83B 5,723B 88.53B 602B 240B 3,054B 229B 224B 9,640B P/E 2026 *
25.6x
P/E 2027 * 18.6x
Enterprise Value 84.41B 94.12B 77.15B 70.42B 133B 8,847B 137B 930B 371B 4,721B 353B 346B 14,903B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.72x
Free-Float
99.99%
Yield 2026 *
0.25%
Yield 2027 * 0.95%
1 day-1.04%
1 week+9.89%
Current month+9.89%
1 month+30.50%
3 months+11.58%
6 months+50.30%
Current year+50.18%
1 week 51.36
Extreme 51.36
56.6
1 month 43.08
Extreme 43.08
56.6
Current year 32.96
Extreme 32.96
56.6
1 year 26.18
Extreme 26.175
56.6
3 years 18.38
Extreme 18.378
56.6
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 69 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Buy

Director

1,900 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%+9.89%+113.32%+34.15% 60.88B
-0.79%-4.48%+46.48%+118.69% 1,206B
+1.43%+1.11%+48.05%+83.72% 665B
+1.07%-1.21%+32.92%+105.10% 515B
-0.36%-3.25%+45.42%+63.89% 381B
-0.14%-1.87%+70.06%+40.55% 362B
-0.78%-0.52%+30.47%+56.79% 307B
-0.80%-0.21%+7.98%+36.97% 289B
+0.03%-1.20%+43.79%+68.49% 249B
-0.41%-2.22%+40.43%+114.24% 207B
Average -0.18%-0.40%+47.89%+72.26% 424.06B
Weighted average by Cap. -0.06%-1.79%+43.72%+85.55%

Financials

2026 *2027 *
Net sales 45.97B 51.25B 42.01B 38.35B 72.25B 4,818B 74.53B 506B 202B 2,571B 192B 188B 8,115B 47.19B 52.61B 43.13B 39.37B 74.17B 4,946B 76.51B 520B 207B 2,639B 197B 193B 8,331B
Net income 2.11B 2.35B 1.93B 1.76B 3.31B 221B 3.42B 23.21B 9.25B 118B 8.82B 8.63B 372B 2.86B 3.19B 2.61B 2.39B 4.5B 300B 4.64B 31.51B 12.57B 160B 11.97B 11.71B 505B
Net Debt 29.81B 33.24B 27.25B 24.87B 46.86B 3,124B 48.34B 328B 131B 1,667B 125B 122B 5,263B 26.71B 29.78B 24.41B 22.28B 41.98B 2,799B 43.3B 294B 117B 1,493B 112B 109B 4,715B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,775
Date Price Change Volume
06/11/26 €55.58 -1.14% 4,309,484
05/11/26 €56.22 +3.65% 4,889,400
04/11/26 €54.24 +4.63% 4,500,817
03/11/26 €51.84 +3.64% 7,668,634
02/11/26 €50.02 -1.11% 2,039,872
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
55.58EUR
Average target price
59.83EUR
Spread / Average Target
+7.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock